A taskforce co-chaired by France’s Ministerial Delegation for Digital Health and the European Network for Health Technology Assessment (EUnetHTA) has been launched with the aim of establishing “real-world-ready” recommendations on how best to evaluate the cost and clinical-effectiveness of digital medical devices (DMDs).
In a statement published on 26 October, the French National Authority for Health (HAS) outlined how key representatives from...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?